Colorado Court of Appeals Opinion - In re A.R.
Summary
The Colorado Court of Appeals affirmed a probate court's order authorizing the involuntary administration of medications to an individual deemed incompetent to proceed in a criminal case. The court found the order was necessary due to the individual's severe schizoaffective disorder and deteriorating physical condition.
What changed
The Colorado Court of Appeals, in case number 25CA2026, affirmed a lower court's decision authorizing the involuntary administration of antipsychotic, mood-stabilizing, and anxiolytic medications to an individual identified as A.R. The appellate court's opinion, announced on March 12, 2026, addresses A.R.'s appeal of the probate court's order, which was granted based on findings that A.R. suffered from a severe schizoaffective disorder, impaired judgment, and a deteriorating physical condition due to refusal to eat, necessitating treatment for her well-being.
This appellate decision has implications for legal professionals and healthcare providers involved in involuntary commitment and treatment cases within Colorado. While this specific case is non-precedential, it reinforces the legal framework for authorizing involuntary medication when a patient's mental illness poses a risk to their health and safety. Regulated entities should note the detailed factual findings regarding A.R.'s condition, including weight loss and paranoia, which supported the court's decision. No specific compliance deadlines or penalties are detailed in this opinion, as it pertains to the affirmation of a prior court order.
What to do next
- Review case law regarding involuntary medication orders in Colorado.
- Ensure proper documentation and expert testimony support petitions for involuntary treatment.
Source document (simplified)
Jump To
Support FLP
CourtListener is a project of Free
Law Project, a federally-recognized 501(c)(3) non-profit. Members help support our work and get special access to features.
Please become a member today.
March 12, 2026 Get Citation Alerts Download PDF Add Note
Peo in Interest of AR
Colorado Court of Appeals
- Citations: None known
- Docket Number: 25CA2026
Precedential Status: Non-Precedential
Combined Opinion
25CA2026 Peo in Interest of AR 03-12-2026
COLORADO COURT OF APPEALS
Court of Appeals No. 25CA2026
City and County of Denver Probate Court No. 25MH937
Honorable Beth A. Tomerlin, Magistrate
The People of the State of Colorado,
Petitioner-Appellee,
In the Interest of A.R.,
Respondent-Appellant.
ORDER AFFIRMED
Division II
Opinion by JUDGE KUHN
Fox and Sullivan, JJ., concur
NOT PUBLISHED PURSUANT TO C.A.R. 35(e)
Announced March 12, 2026
Miko Brown, City Attorney, Daniel Horwitz, Assistant City Attorney, Denver,
Colorado, for Petitioner-Appellee
Richard Slosman, Boulder, Colorado, for Respondent-Appellant
¶1 A.R. appeals the probate court’s order authorizing the
involuntary administration of medications to her. We affirm.
I. Background
¶2 In March 2025, A.R. was deemed incompetent to proceed in a
criminal case. The district court committed her to the custody of
the Colorado Department of Human Services for a competency
evaluation or restoration services. A Denver Health Medical Center
psychiatrist, Dr. James Haug, treated A.R. at the jail while she
awaited placement at a competency restoration facility.
¶3 In September 2025, Denver Health filed a petition for
authorization to administer antipsychotic, mood-stabilizing,
anxiolytic, and side-effect medications to A.R. without her consent.1
According to the petition, A.R. requires treatment for her
schizoaffective disorder, bipolar type, with manic symptoms. The
petition detailed A.R.’s deterioration at the jail, most notably that
her body weight had dropped from 140 pounds to 96 pounds due to
1 Specifically, the petition sought permission to involuntarily
administer Haldol, Risperdal, Zyprexa, Depakote/Depakene,
lithium, Ativan, Benadryl, and Cogentin, along with their long-
acting counterparts where appropriate. The petition also sought
permission to conduct lab testing.
1
her refusal to eat consistently, her demands for particular types of
foods, and her recent belief that the food is laced with arsenic. The
petition also described A.R.’s manic symptoms, including yelling
and swearing at jail and Denver Health personnel and expressing
paranoia that jail deputies are trying to sexually assault her. The
petition also reported that A.R. had stopped wearing clothing
altogether.
¶4 At the hearing on the petition, Dr. Haug and A.R. both
testified. Dr. Haug, whom the parties stipulated was an expert in
psychiatry, testified that A.R.’s schizoaffective disorder — which he
described as “severe” — constitutes a substantial disorder that
impairs her judgment, her capacity to recognize reality, and her
ability to control her behavior. He reported that A.R.’s physical
condition was “fairly concerning” and that if she continues to not
eat, she will die of starvation. He also testified that “it’s become
clear” that A.R.’s refusal to eat is caused by her mental illness, not
just having very particular food preferences. He further testified
that A.R. remaining in a state of mania long term will damage her
brain, which will make it more difficult to treat her and lead to a
lower baseline of functioning following treatment.
2
¶5 Dr. Haug opined that medication is a “hundred percent”
essential to effectively treat A.R.’s condition and that without the
requested medications, she is at risk of significant and likely long-
term deterioration of both her physical and mental condition.
However, when Dr. Haug attempted to discuss the medications with
A.R., “[s]he aggressively told [him] she doesn’t need medications and
flipped [him] off.” Dr. Haug also mentioned that A.R. had been
treated with Geodon and lithium during a 2021 hospitalization at
Denver Health, and although lithium was one of the medications he
was requesting, he was not requesting Geodon because it must be
taken orally with at least 350 calories, but she was not eating food.
¶6 A.R. testified that she did not agree with any of Dr. Haug’s
testimony, including his schizoaffective disorder diagnosis, but then
said that she agreed with a previous diagnosis that she is “autistic,
also schizophrenic with also full body disability.” On cross-
examination, she was asked what treatment she was receiving for
her schizophrenia, and she responded, “the greatest treatment that
I need is actually nutritional, and I need food before we can
continue with anything else. And I absolutely refuse treatment
from Denver Health.” She testified that she has particular food
3
requirements because of severe indigestion, the food she has been
served is “adulterated” because it is “spoiled rotten,” and she
“need[s] to gain at least [ten] to [twenty] pounds before medications
can safely be considered.” As for medications, she testified that she
was only willing to take “very minimal[]” amounts of Geodon and
lithium.
¶7 However, Dr. Haug testified that giving A.R. only small
amounts of Geodon and lithium, and only after she increases her
weight, “would not be a successful strategy,” and instead would “be
a dangerous strategy,” because (1) it has been impossible to
accommodate her dietary requests, which are driven by her manic
symptoms; and (2) it would encourage her not to gain weight so she
won’t have to take medication.
¶8 After hearing the testimony, the probate court found that Dr.
Haug’s testimony was credible and that A.R.’s testimony was not
credible. The court examined each of the four elements of the test
from People v. Medina, 705 P.2d 961, 973 (Colo. 1985), concluded
that Denver Health had met its burden of proving all four elements,
and granted the petition.
4
II. Analysis
¶9 The parties agree that the Medina test applies in this case.2
However, A.R. contends that the evidence was insufficient to prove
any of the four Medina elements.
A. Applicable Law and Standard of Review
¶ 10 Under the Medina test, a court may authorize the involuntary
administration of medication if the petitioner demonstrates by clear
and convincing evidence that
(1) the patient is incompetent to effectively participate in the
treatment decision;
(2) the treatment is necessary to prevent a significant and
likely long-term deterioration in the patient’s mental health
condition or to prevent the likelihood of the patient causing
serious harm to herself or others at the institution;
(3) a less intrusive treatment alternative is not available; and
2 When the state seeks an order authorizing involuntary
administration of medication solely to restore a defendant to
competency to stand trial, a court must apply the test set forth in
Sell v. United States, 539 U.S. 166, 180-81 (2003). But “if forced
medication is warranted for a different purpose, . . . related to the
individual’s own interests,” then applying state-law tests, which
account for those purposes, is preferred. Id. at 182. We agree with
the parties that the Medina test applies to this order.
5
(4) the patient’s need for treatment is sufficiently compelling to
override any bona fide and legitimate interest of the patient in
refusing treatment.
¶ 11 Application of the Medina test involves mixed questions of fact
and law. People v. Marquardt, 2016 CO 4, ¶ 8. We defer to the
probate court’s factual findings if they have record support, but we
review de novo the court’s legal conclusions. Id. Resolving conflicts
in the testimony and determining the credibility of the witnesses are
matters solely within the province of the probate court. People in
Interest of Ramsey, 2023 COA 95, ¶ 23.
¶ 12 In a sufficiency challenge, we must determine whether the
evidence, viewed as a whole and in the light most favorable to the
petitioner, is sufficient to support the probate court’s order. People
in Interest of R.K.L., 2016 COA 84, ¶ 13. The testimony of the
physician seeking to administer treatment may be sufficient,
without more, to satisfy the Medina test. Id. at ¶ 30.
B. Incompetency to Make Treatment Decisions
¶ 13 The first Medina element requires the petitioner to establish
“the patient’s incompetency to make treatment decisions.” Id. at
6
¶ 32 (quoting Medina, 705 P.2d at 973). For the petitioner to
prevail, the probate court must be satisfied that “the patient’s
mental illness has so impaired [her] judgment as to render [her]
‘incapable of participating in decisions affecting [her] health.’”
People in Interest of Strodtman, 293 P.3d 123, 132 (Colo. App. 2011)
(quoting Medina, 705 P.2d at 973).
¶ 14 The probate court found that A.R. is incompetent to effectively
participate in treatment decisions because of her delusions and
paranoia, which lead to “endless” demands and bargaining about
food and medications. The court also pointed out that “[A.R.’s]
testimony is that she’ll only take medications that are . . . at her
direction and her decision. That’s not informed conversation with a
medical doctor trained in psychiatry about a condition and what
would alleviate symptoms of that condition or help someone to
function better.”
¶ 15 Those findings are well supported by Dr. Haug’s testimony.
Dr. Haug opined that A.R. is incompetent to effectively participate
in treatment decisions, explaining that A.R. “does not believe any of
her behavior currently is related to mental illness.” A.R. appeared
to confirm that position during her testimony when she denied
7
having a mood disorder and instead blamed her behavior on “the
effects of starvation.” Further, Dr. Haug testified that he has not
been able to communicate with A.R. recently because she has either
“not [been] responding to [him]” or she has been “flipping [him] off
and yelling.” Refusing to communicate with a treatment provider
does not enable effective participation in treatment decisions.
¶ 16 A.R. argues that she is competent to effectively participate in
treatment decisions because “she recognized the need to take
Geodon and lithium” and was willing to do so “as her weight
increase[s] to a safe measure.” But that argument somewhat
mischaracterizes A.R.’s testimony at the hearing. She testified that
she was “willing to accept small amounts of Geodon and lithium
only, but that is after I gain at least [ten] to [twenty] pounds and an
evaluation is done after that, if it’s still needed.” (Emphasis added.)
Further, when she was asked about treating her schizophrenia, she
responded that “the greatest treatment that I need is actually
nutritional.”
¶ 17 Dr. Haug opined that taking a small amount of Geodon and
lithium only after A.R. increases her weight would not be successful
and would in fact be a dangerous strategy. Further, Dr. Haug
8
opined that A.R.’s untreated schizoaffective disorder is what led to
her behaviors and beliefs surrounding food, which led to her
extreme weight loss. He testified that this calls into serious
question how A.R. would be able to gain ten to twenty pounds while
continuing to go untreated. As noted above, the probate court
found Dr. Haug’s testimony on all of these points credible. See
Ramsey, ¶ 23.
C. Lont-Term Mental Deterioration
or Likelihood of Harm
¶ 18 The probate court also found that the requested medications
were necessary both (1) “to prevent a significant and likely long-
term deterioration in [A.R.’s] mental condition” and (2) “to prevent
the likelihood of [A.R.] causing serious harm to herself in the
institution because she’s starving herself to death, and that is a
direct result of the psychosis and her mental condition.”
¶ 19 Those findings are also well supported by Dr. Haug’s
testimony. As described above, he testified that A.R. continuing to
be in a state of mania long term will damage her brain and lead to a
lower baseline of functioning. And he opined that A.R.’s untreated
9
schizoaffective disorder jeopardized not only her health but her life
itself.
¶ 20 A.R. asserts that she “was working with jail staff to gain
weight” and argues that taking Geodon will encourage further
weight gain because it must be taken with 350 calories. But we see
no evidence in the record supporting this assertion. To the
contrary, the record indicates that she weighed ninety-six pounds
on the date the petition was filed, but at the hearing six days later,
A.R. reported that she currently weighs ninety-two pounds. The
probate court’s findings, which are well supported by Dr. Haug’s
testimony, indicate that the requested medications are necessary to
reverse the deterioration in A.R.’s physical and mental health.
D. No Less Intrusive Alternative
¶ 21 A.R. contends that there was an appropriate, less intrusive
alternative to the requested medications, namely, giving A.R.
“appropriate, unspoiled and healthy food” and “Geodon and a low
dosage of lithium when she [reaches] a safe weight.”
¶ 22 We have already addressed and rejected A.R.’s arguments
regarding treating her with a small amount of Geodon and lithium,
supra Part II.C. In terms of A.R.’s argument about “appropriate,
10
unspoiled and healthy food,” the probate court specifically
addressed that issue. The court said that her belief that the food is
rotten is evidence that she can’t recognize reality and that she has
impaired cognition and thought processes. The court also noted the
evidence that A.R. refused to eat if her precise demands were not
met, one of which was being given exactly four salt packets and four
pepper packets with her meal. The court then found that “these
demands . . . can never be met because it’s an endless cycle of
demands. It’s not enough. It’s not good enough. . . . [A.R.’s]
mental illness drives this, that she has no apparent control over
these . . . demands or how she feels at this point.” Dr. Haug’s
testimony amply supports the court’s findings on these points. He
testified that while the jail staff had gone to extreme lengths to
accommodate A.R.’s demands, those demands had continued to
change, and she continued to not eat.
E. Need for Medication Overrides
Legitimate Reason to Refuse
¶ 23 In analyzing the fourth Medina element, a court first
determines “whether the patient’s refusal [of treatment] is bona fide
and legitimate.” Medina, 705 P.2d at 974. If it is, the court then
11
determines “whether the prognosis without treatment is so
unfavorable that the patient’s personal preference must yield to the
legitimate interests of the state in preserving the life and health of
the patient placed in its charge and in protecting the safety of those
in the institution.” Id.
¶ 24 A.R. argues that “[s]he has had experiences with some [of the
requested] medications and has experienced significant side-
effects.” However, she did not cite any part of the record to support
that argument, see C.A.R. 28(a)(7)(B), and we find no record
support for it. However, Dr. Haug was specifically asked whether
A.R. had ever been treated with the requested antipsychotic, mood-
stabilizing, and anxiolytic medications. In terms of the three
antipsychotic medications, Dr. Haug testified that A.R. had
previously been treated at Denver Health with Zyprexa and Haldol
and there was no comment in the medical records that she
experienced any side effects from them. In terms of the two mood-
stabilizing medications being requested, Dr. Haug testified that he
would begin treating her with lithium because she has taken it
previously and “tolerated it well.” And in terms of the anxiolytic
medication Ativan, Dr. Haug testified that it “has the fewest side
12
effects of any of those other medications” and “works the fastest,”
that A.R. had previously been treated at Denver Health with it, and
“[t]here was no note [in the medical records] that she experienced
any issues with [it].”
¶ 25 A.R. also argues that she “is legitimately concerned that
without first gaining weight, the risks from these medications are
increased, and that the involuntary medications requested would be
detrimental to her.” But the probate court did not find A.R.’s
testimony to be credible, and Dr. Haug, whose testimony the court
did credit, did not express concerns during his testimony regarding
A.R. taking the requested medications at her current weight.
¶ 26 We therefore cannot conclude that A.R.’s arguments on appeal
reveal any bona fide and legitimate reason for refusing the
requested medications. And the probate court found that “[A.R.’s]
mental deterioration is such, at this point, . . . that she’s unable to
actually express [a] bona fide and legitimate interest in refusing
treatment because her deterioration is such that she can’t really
distinguish between reality and fantasy-induced psychosis.” In any
event, the probate court’s findings and Dr. Haug’s testimony
establish that the severity of A.R.’s condition and her compelling
13
need for the requested treatment override any bona fide and
legitimate interest she has in refusing treatment.
¶ 27 Given all of this, we conclude that the evidence, viewed as a
whole and in the light most favorable to the petitioner, is sufficient
to support the probate court’s order. See R.K.L., ¶ 13.
III. Disposition
¶ 28 The order is affirmed.
JUDGE FOX and JUDGE SULLIVAN concur.
14
Related changes
Source
Classification
Who this affects
Taxonomy
Browse Categories
Get State Courts alerts
Weekly digest. AI-summarized, no noise.
Free. Unsubscribe anytime.
Get alerts for this source
We'll email you when CO Court of Appeals Opinions publishes new changes.